原发性高血压肾损害与环境因素及HLA-DRB1 SNPs相关性研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
研究背景:肾脏是EH的主要靶器官损伤之一,早期损伤主要表现为微量蛋白尿的增加。严重肾脏损害可致肾功能衰竭,故对疾病的早期诊断有利于疾病的防治和延缓病情的进展。研究表明多种因素参与EH肾损害的形成,如环境因素和基因因素等。HLA是目前已知的最复杂的人类基因复合体,近年来HLA与疾病的关联性已成为群体遗传学及免疫相关疾病研究的热点。
     目的:研究原发性高血压肾损害的相关因素,探讨HLA-DRB1单核苷酸多态性与原发性高血压肾损害的关联,为人群高血压肾损害的防治提供科学依据。
     方法:筛查纳入185例原发性高血压患者,分为单纯高血压组和高血压肾损害组。详细询问病史及查询病历,并检测腰腹围、体重指数、空腹血糖、总胆固醇、甘油三酯、尿酸、白蛋白等。运用PCR-LDR技术,检测HLA-DRB1rs2308765、rs9269186及rs3135388三个SNPs位点与原发性高血压肾损害的关联。最后应用SAS统计软件对资料进行处理。
     结果:(1)对所研究的相关因素进行单因素分析,结果发现年龄、空腹血糖、高血压病程、血压控制水平、是否合并糖尿病在两组间的差异具有统计学意义(P<0.05),其他因素在两组间无相关性。进行非条件Logistic回归分析后,血压控制水平、是否合并糖尿病与肾损害仍相关联(P<0.05)。(2)rs2308765、rs9269186及rs3135388基因型频率均符合H-W遗传平衡定律,经统计分析发现三个位点在两组间基因型及等位基因频率分布均无统计学意义(P>0.05)。
     结论:(1)血压控制水平、合并糖尿病可能是原发性高血压肾损害的危险因素;(2)本研究未发现性别、年龄、腰腹围、体重指数、尿酸、空腹血糖、总胆固醇、甘油三酯、高密度胆固醇脂蛋白、低密度胆固醇脂蛋白等与原发性高血压肾损害有关;(3)HLA-DRB1rs2308765、rs9269186及rs3135388单核甘酸多态性与原发性高血压肾损害无关。
Background: The kidney is the main target organ damage in EH, early damage ismainly manifested in the increase in microalbuminuria. Severe kidney damage can lead torenal failure.Therefore, the early diagnosis is benefit for the disease prevention andtreatment,and delay disease progression. The study showed that a variety of factorsinvolved in the formation of the EH kidney damage, such as environmental factors andgenetic factors. HLA is the most complex gene complex. In recent years, the association ofHLA and disease has become the research focus of the population genetics andimmune-related diseases.
     Objective:To research kidney damage related factors in elderly essentialhypertension,discusses the relationship of HLA-DRB1SNP and primary hypertension renaldamage,and provide a scientific basis for prevention and treatment of hypertension kidneydamage.
     Methods:Screening185cases with essential hypertension,divided into twogroups,simple hypertension and hypertensive kidney damage.Ask for details of the historyand inquire the medical records,and survey waist circumference,body mass index,fastingglucose,total cholesterol,triglycerides,uric acid,albumin,and so on.Use of PCR-LDRdetection the relationship of HLA-DRB1rs2308765,rs9269186,rs3135388SNPs andessential hypertension kidney damage.Finally,use the SAS statistical software for dataprocessing.
     Results:(1)Trough the univariate analysis of the relevant factors found that age,fastingblood glucose,the time of hypertension,blood pressure control,and whether diabetesmellitus has statistically significance in the two groups(P<0.05),other factors has nocorrelation between the two groups.Logistic regression analysis,blood pressurecontrol,creatinine, diabetes still has statistically significance in the two groups(P<0.05).(2)rs2308765, rs9269186and rs3135388genotype frequencies are in line with H-W geneticequilibrium, statistical analysis found that three sites in the distribution of genotypes andallele frequencies had no statistically significant between the two groups(P>0.05).
     Conclusion:(1)Blood pressure control,diabetes mellitus may be risk factors of theelderly essential hypertension kidney damage.(2) This experiment did not found sex,age,waistline,abdomen circumference,body mass index,uric acid,fasting plasmaglucose,total cholesterol, triglyeride, high density lipoproteinmay have relationship withthe elderly essential hypertension kidney damage.(3)HLA-DRB1rs2308765, rs9269186and rs3135388single nucleotide polymorphism may have no relationship with the elderly
引文
[1]王庆芳,张强,姜晓凤,等.高血压慢性肾脏病患者的流行病学研究[J].医药论坛杂志,2008,10(29):8-10.
    [2] Cristina Barlassina,Chiara Lanzani,Paolo Manunta,Genetics of essential hypertension:From families to genes[J]. J Am Soc Nephrol,2002,13:155-164.
    [3] Fabris B,Bortoletto M,Candido R.Genetic polymorphisms of the Rennin-angiotensin-aldostemne system and renal insufficiency in essential hypertension.Journal ofHypertension,2005,2:309-316.
    [4]刘艳,金玮,姜正文,等.血管紧张素原基因的六种单核苷酸多态与原发性高血压的相关性[J],中华医学遗传学杂志,2004,21:116-119.
    [5]李庆祥,朱晓玲,张宇清等.血管紧张素ⅡI型受体A1166C多态性与高血压左心室肥厚的相关性研究[J].中国综合临床,2006,22:40-42.
    [6] Zhang Y,Zhang KX,Wang GL,et a1.Angiotensin II type2receptor gene polymorphismsand essential hypertension[J].Acta Pharmacol Sin,2003,24:1089-1093.
    [7]张静.激素、基因与高血压[J].继续医学教育,2002,3(16):48-50.
    [8]王克志,杜贻萌,路方红.原发性高血压的候选基因研究[J].中国慢性疾病预防与控制,2001,5(9):239-241.
    [9] Halbesma N,Brantsma AH,Bakker SJ,et al.Gender differences in predictors of thedecline of renal function in the general population[J].Kidney Int,2008Aug,74(4):505-12.
    [10]Hitha B,Pappachan JM,Pillai HB,et al.Microalbuminuria in patients with essentialhypertension and its relationship to target organ damage:an Indian experience[J].SaudiJ Kidney Dis Transpl,2008,19(3):411-419.
    [11]杨瑞丽,张龙,杜传荣.老年高血压肾损害相关因素及临床分析[J].山东医药,2008,42(48):54-55.
    [12]Collins FS,Brooks LD,Ahakravarti A,et al.DNA polymorphism discovery resource forresearch on human genetic variation[J],Genome Res,.1998,8:1229.
    [13]Tajik N,Shahsavar F,Nasiri M,et al.Compound KIR-HLA genotype analyses in theIranian population by a novel PCR-SSP assay[J]. Int J Immunogenet,2010Jun;37(3):159-168.
    [14]Nickerson DA,Taylor SL,Weiss KM,et al.DNA sequence diversity in a9.7kb region ofthe human lipoprotein lipase gene[J].Nature Genetics,1998,19:233-240.
    [15]吴学飞,巢国祥,杨立坤.尿微量白蛋白的测定及其临床意义[J].临床和实验医学杂志,2008,7(12):7.
    [16]罗琳.尿微量白蛋白测定在高血压早期肾损害诊断中的应用[J].实验与检验医学,2008,26(6):710.
    [17]Parving HH,Jenser HA,Mogensen CE,et al.Increased urinary albumin excretion ratebenigness ential hypertension[J].Lancet,1974,1:1190-1192.
    [18]Cerasola G,Cottone S,Dlgnoto G,et al.Microalbuminuria,renal dysfunction andcardiovascular complication in essential hypertension[J].Hypertension,1996,14(7):915-920.
    [19]Veerman DP,Blok K,Montfrans A.Relationship of steady state and ambulatory bloodpressure variability to left ventricular mass and urinary albumin excretion in essentialhypertension[J].Hypertension,1996,9(5):455-460.
    [20]Andrew S,Levey MD,Jose f Coresh PD,et al.National Kidney Foundation.K/DOQI forchronic kidney disease:evaluation,classification,and stratification.Am J KidneyDis,2002,39(2Suppl1):S1-S266.
    [21]Abitbol C,Zillerulo G,Freundlich M,et a1.Quantitation of proteinuria with urinarypmtein/creatinine ratios and randomtesting with dipsticks in nephrotic children.JPediatr,1990,l16:243-247.
    [22]Assadi FK.Quantitation of microalbuminuria using randomurine samples.PediatrNephml,2002,17:107-l10.
    [23]Bidani AK,Griffin KA.Pathophysiology of hypertensive renal damage:implications fortherapy.Hypertension,2004,44:595-601.
    [24]Bidani AK,Griffin KA.Long-term renal consequences of hypertension for normal anddiseased kidneys.CurrOpin Nephrol Hypertens,2002,11:73-80.
    [25]梅长林.高血压小动脉硬化与慢性肾功能衰竭[J].中国实用内科杂志,1997,17(6):323-324.
    [26]樊玉兰.肾功能指标联合检测对老年高血压病早期肾损害的诊断价值[J].中国卫生检验杂志,2010,12(20):3518-3519.
    [27]原守平.尿ALB、NAG、THP、A1-MG、TRF对早期诊断高血压肾损害的意义探讨[J].福建医药杂志,2010,6(32):103-104.
    [28]李招云,吴晓宇.高血压病患者肾脏早期损害指标的探讨[J].中华检验医学杂志,2001,(5):282-284.
    [29]Levey AS,Eckardt KU,Tsukamoto Y,et al.Definition and classification of chronickidney disease:a position statement from KidneyDisease:Imp roving GlobalOutcomes(KD IGO)[J]. Kidey Int,2005,67(6):2089-2100.
    [30]高秀林.高血压肾损害发病机制的研究进展[J].北京医学,2007,9(29):559-561.
    [31]Palmer BE.Impaired renal autoregulation:implication for the genesis of hypertensionand hypertension-induced renal injury.Am J Med Sci,2001,321:388-400.
    [32]Lavoie P,Robitaille G,Agaharazii M,et al.Involvement of transforming growthfactorbeta in the pathogenesis of hypertension in rats with chronic renal failure.JHypertens,2004,22(Suppl):80.
    [33]Lebel M,Lariviere R.Endothelin-1in chronic renal failure and hypertension.Can JPhysiol Pharmacol,2003,81:607-621.
    [34]邹斌,吴延庆.活性氧与高血压肾损害关系研究进展[J].中国中西医结合肾病杂志,2004,5:60-62.
    [35]Recasens M.Ricart W.Fernandez-Real JM.Obesity and inflammation.Rev Med UnivNavarra,2004,48:49-54.
    [36]杨和平,周爱儒,余振球,等.原癌基因、免疫与高血压[J].实用高血压学,1993,154-155.
    [37]Luvara G,Pueyo ME,Philippe M,et a1.Chronic blockade of NO synthase activityinduces a pminflammatory phenotype in the arterial wall:prevention by angiotensin IIantagonism.Arterioscler Thromb Vase Bio1,1998,18(9):1408-1416.
    [38]Simmons EM,Himmelfarb J,Sezer MT,et al.Plasma cytokine levels predict mortality inpatients with acute renal failure [J].Kidney Int,2004,65:1357-1365.
    [39]Pecoits-Filho R,Barany P,Lindholm B,et al.Interleukin-6is an indendent predictor ofmortality in patients starting dialydsis treatment [J].Nephrol Dial Transplant,2002Sep,17(9):1684-1688.
    [40]Nickenig G.Central role of the AT1-receptor in atherosclerosis.J Hum Hypertens,2002,16:26-33.
    [41]Li JJ,Fang CH,Jiang H,et a1.Activation of nuclear factor-kappaB and correlation-withelevated plasma C-reactive protein in patients with unstable angina.Heart LungCirc,2004,13:173-178.
    [42]Kincaid-Smith P.Hypothesis:obesity and the insulin resistance syndrome play a majorrole in end-stage renal failure attributed to hypertension and labelled hypertensivenephrosclerosis’.J Hypertens,2004,22:1051-1055.
    [43]Morris AD,Petrie JR,Conn ell JM,et al.Insulin and hypertension.J Hypertens,1994,12:633-642.
    [44]Su DF and Miao CY.Blood pressure variability and organ damage.Clin Exp PharmacolPhysiol,2001,28:709-715.
    [45]De Mello WC.Danser AH.AngiotensinⅡ and the heart:on the intraerine rennin-angiotensin system.Hypertension2000,35:1183-1188.
    [46]Cao Z,Dean R,Wu L,et a1.Cooper ME.Role of angiotensin receptor subtypes inmesenterie vascular proliferation and hypertrophy.Hypertension1999,34:408-414.
    [47]Jan klein,Akie sato.The HLA system: First0f tw0parts [J].N Engl J Med,2000,343(10):702-709.
    [48]孙宁玲,阎文瑛,王申五,等.原发性高血压与HLA-DRB等位基因相关的研究[J].北京医科大学学报,1997,29(4):348-351.
    [49]BVidan J eras,A Greg0ric,B Jurca,et al.Possihle inf1uence of genes located onchromosome6within or near to the major histocompatibility complex on developmentof essential hypertension[J].P FIugers Arch,2000,439(3Supp1):R60-R62.
    [50]JM zabay,J Marco,J soler,et a1.Association of HLA-DRB3*0202and serum IgGantibodies to Chlamydia pneumoniae with essential hypertension in a highlyhomogeneous population from Majorca(Bal earic Is lands,Spain)[J].Human Hyper-tension,2005,19:615-622.
    [51]胡大春,邵剑春,陈爱华,等.HLA2DQB1等位基因与高血压病的相关性研究[J].中国免疫学杂志,2008,24(5):434-435.
    [52]沈乃莹,闫征,何培英,等.HLA-DQA1*0301及*0103与腔隙性脑梗死和原发性高血压的遗传易感性研究[J].中华微生物学和免疫学杂志,2001,21(5):497-500.
    [53]王红英,邢建新,周康,等. HLA-DQA1等位基因与新疆哈萨克族原发性高血压的相关性[J].西安交通大学学报(医学版),2009,30(4):402-404.
    [54]徐金瑞,杨易,张东涛,等.宁夏回族原发性高血压人群HLA-DQB1基因多态性分析[J],吉林大学学报(医学版),2009,6(35):1103-1106.
    [55]Nunez DJ,Clifford CP,alMahdawi S,et al.Hypertensive cardiac hypertrophy Is geneticvariance the missing link?[J]. Br J Clin Pharmacol,1996,42(1):107-117.
    [56]Verhaaren H.A,Schieken R.M,Mosteller M,et al.Bivariate genetic analysis of leftventricular mass and weight in pubertal twins(the Medical College of Virginia twinstudy)[J]. Am J Cardiol,1991,68(6):661-668.
    [57]Tanase H,Yamori Y,Hansen CT,et al.Heart size in inbred strains of rats. Part1.Geneticdetermination of the development of cardiovascular enlargement in rats[J].Hypertension,1982,4(6):864-872.
    [58]Emmanuel J,Diamantopou1os,Emmanuel A,et al.As sociation of specific HLAphenotypes with left ventricular mass and carotid intima-media thickness inhypertensives[J]. Am J Hypertensi0n,2001,14:632-636.
    [59]Vlachonikolis IG,Tarassi KE,Chatzis NA,et a1.HLA phenotypes as promoters ofcardiovascular remodlling in subjects with arterial hypertension[J].J Hum Hypertens,2003,17(1):63-68.
    [60]陈爱华,李海燕,胡大春,等.云南汉族原发性高血压左室重构与HLA-DRB1等位基因的相关性研究[J].云南医药,2009,30(1):2-6.
    [61]陈爱华,李海燕,胡大春,等.云南汉族原发性高血压左室重构与HLA-DQA1等位基因的相关研究[J].中国分子心脏病学杂志,2008,8(6):353-356.
    [62]王新德主编.脑血管疾病[M].北京:中国科学技术出版社,1993,121-125.
    [63]郭淮莲,蔡转,赵修竹,等.脑梗塞与HLA-I、Ⅲ单体型关联性的初步研究[J].同济医科大学学报,1994,23(4):280.
    [64]王增慧,何旦莎,郭秋霞,等.HLA与原发性高血压、脑中风关系的调查[J].中华神经精神科杂志,1991,24(3):181.
    [65]Levy M,Lesavre PH.Genetic factors in IgA nephropathy(Bergers disease) in Advancesin Nephrology. Maxwell:Grunfeld Bach Kreis,1992,23-51.
    [66]陈楠,范丽安,董德长,等.人类白细胞抗原与IgA肾病关联及其临床意义[J].中国免疫学杂志,1997,2(12):85-87.
    [67]Richrnan AV,Mahoney JJ,Fuller TJ et al. Higher prevalence of HLA-B12in patientswith IgA nephropathy.Ann Intern Med,1979Feb,90(2):201.
    [68]Hiki Y,Kobayashi Y,Tateno S et al.Strong association of HLA-DR4benigh IgAnephropathy.Nephron,1982,32(3):222-226.
    [69]苏家光,梁伶,刘栋华,等.HLA-DRB1,DQA1等位基因与广西壮族系统性红斑狼疮器官系统损害相关性研究[J].中国皮肤性病学杂志,2006,8(20):461-463.
    [70]Fox CS,Larson MG,Leip EP,et al.Predictors of new-onset kidney disease in acommunity-based population. JAMA,2004,291:844-850.
    [71]WeirMR.The role of combination antihypertensive therapy in the prevention andtreatment of chronic kidney disease. Am J Hypertens,2005,18:100-105.
    [72]BakrisGL.Protecting renal function in the hypertensive patient clinical guidelines. AmJH ypertens,2005,18:112-119.
    [73]樊晓寒,惠汝太.高血压肾脏损害类型和机制研究进展[J].临床内科杂志,2008,10(25):716-718.
    [74]Johnson RJ,SegalMA,Srinivas T,et al. Essential Hypertension, Progressive RenalDisease, and Uric Acid: A Pathogenetic Link. J Am Soc Nephro,2005,16:1909-1919.
    [75]Smith SK, S vetkey L. Racial differences in the incidence and progressin of renaldisease Kidney Int,1991Nov,40(5):815-822.
    [76]Marco Severgnini, Paola Cremonesi,Clarissa Consolandi,et al.ORMA:a tool foridentification of species-specific variations in16S rRNA gene and oligonucleotidesdesign[J]. Nucleic Acids Res,2009Sep,37(16):e109.
    [77]袁伟杰,崔若兰.对高血压肾损伤临床应进一步思考的问题[J].中华肾脏病杂志,2005,21:572.
    [78]WU JT. Advanced glycosy lation end products: a new diseasemarker for diabetes andaging[J].Chin Lab Anal,1993,7:252-254.
    [79]Giampietro O,Matteucci E,Pedrinelli R.Erythrocyte sodiumhydrogenexchange andmicroalbuminuria in type I diabetes [J].Dia Car,1996,19:995-998.
    [80]陈香美.高血压病引起的肾脏损伤[J].中华肾脏病杂志,2005,21:563-565.
    [81]Linda,Mullins,Matthew A,et al.Hypertension,kidney,and transgenics:A fresh perspec-tive [J]. Physiol Rev,2006,86:709-746.
    [82]周淑华,王秀敏,杨磊,等.山东地区汉族寻常型银屑病与HLA-DRB1、DQB1等位基因的相关性研究[J].中国麻风皮肤病杂志,2008,24(3):188-190.
    [83]Kim TJ,Kim TH.Clinical spectrum of ankylosing spondylitis in Korea[J].Joint BoneSpine,2010May;77(3):235-240.
    [84]刘愉,孙利炜,李丽红,等.小儿过敏紫癜与HLA-DRB-1关联性分析[J].中国实验诊断学,2008,12(11):1375-1377.
    [85]Morgan AW,Robinson JI,Conaghan PG,et al.Evaluation of the rheumatoid arthritissusceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4and TRAF1/C5inan inception cohort[J]. Arthritis Res Ther,2010,12(2):R57.
    [86]刘惠琴,陈阿梅.内蒙古地区妊娠高血压病人人类白细胞抗原HLA-DRB1基因多态性研究[J].内蒙古医学院学报,2010,2(32):201-204.
    [87]Takahashi M,Kimura A. HLA and CTLA4polymorphisms may confer a synergisticrisk in the susceptibility to Graves' disease[J]. J Hum Genet,2010Mar,55(5):323-326.
    [88]Delli AJ,Lindblad B,Carlsson A,et al. Type1diabetes patients born to immigrants toSweden increase their native diabetes risk and differ from Swedish patients in HLAtypes and islet autoantibodies[J] Pediatr Diabetes,2010Dec,11(8):513-20.
    [89]苏家光,梁伶,刘栋华,等. HLA-DRB1,DQA1等位基因与广西壮族系统性红斑狼疮器官系统损害相关性研究[J].中国皮肤性病学杂志,2006,8(20):461-463.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700